Loading insider details...
Latest Form 4 (Nov 5, 2026): Exercise/Conversion of 14,305 RLYB shares, $63.7K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 5, 2026 | Rallybio Corp (RLYB) | Exercise/Conversion | 14,305 | $63.7K |
| Nov 2, 2026 | Rallybio Corp (RLYB) | Exercise/Conversion | 3,562 | $8.5K |
| Feb 20, 2026 | Rallybio Corp (RLYB) | Grant/Award | 14,305 | $51.5K |
| May 15, 2025 | Rallybio Corp (RLYB) | Grant/Award | 28,500 | n/a |
| Jan 6, 2025 | Rallybio Corp (RLYB) | Grant/Award | 73,571 | $51.5K |
| Aug 12, 2024 | Iterum Therapeutics plc (ITRM) | Exercise/Conversion | 182,453 | n/a |
| May 17, 2024 | Rallybio Corp (RLYB) | Grant/Award | 16,500 | n/a |
| Mar 11, 2024 | Harpoon Therapeutics, Inc. (HARP) | Grant/Award | 424 | n/a |
| Jan 4, 2024 | Rallybio Corp (RLYB) | Grant/Award | 29,096 | $51.5K |
| Jan 3, 2024 | Harpoon Therapeutics, Inc. (HARP) | Grant/Award | 1,072 | n/a |